35 Briefs Supporting FDA Submitted to U.S. Supreme Court on Mifepristone Decision

Thirty-five amicus briefs on the issue of the FDA’s approval of the abortion drug mifepristone landed in the Supreme Court of U.S. on Tuesday, all in support of the FDA’s position, from submitters ranging from single associations to groups with more than 600 members.
Source: Drug Industry Daily